MIM
MRVI icon

Macroview Investment Management’s Maravai LifeSciences MRVI Stock Holding History

Macroview Investment Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,071
Closed -$7.67K – 618
2024
Q2 		$7.67K Buy
+1,071
New +$9.25K 0.01% 295
2021
Q3 		– Sell
-594
Closed -$25K – 431
2021
Q2 		$25K Buy
+594
New +$23K 0.03% 133

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Macroview Investment Management's MRVI Position: Q3 2024 in Review

Macroview Investment Management sold out of Maravai LifeSciences (MRVI) in Q3 2024, closing a stake of 1,071 shares — an estimated $7.67K sold.

Macroview Investment Management first reported a position in MRVI in Q2 2021 and held it in 2 quarters. The position peaked at $25K in Q2 2021. 217 funds tracked by Wall St. Rank hold MRVI as of Q3 2024.

  • Macroview Investment Management reported no remaining Maravai LifeSciences position as of Q3 2024 after selling out during the quarter.
  • Macroview Investment Management sold 1,071 Maravai LifeSciences shares in Q3 2024, an estimated $7.67K.
  • Macroview Investment Management first reported a position in Maravai LifeSciences in Q2 2021 and held it in 2 quarters.
  • Macroview Investment Management's Maravai LifeSciences position peaked at $25K in Q2 2021.
  • 217 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2024.

Based on Macroview Investment Management's 13F filing for Q3 2024, filed 22 Oct 2024.